Adequan 250 mg/ml Solution for Injection
Adequan 250 mg/ml Solution for Injection
Not authorised
- GLYCOSAMINOGLYCAN POLYSULFATE
Product identification
Medicine name:
Adequan 250 mg/ml Solution for Injection
Active substance:
- GLYCOSAMINOGLYCAN POLYSULFATE
Target species:
-
Horse
Route of administration:
-
Intraarticular use
Product details
Active substance and strength:
-
GLYCOSAMINOGLYCAN POLYSULFATE250.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intraarticular use
-
Horse
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AX12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- Cardboard box with 5 neutral Type I glass ampoules with break ring containing 1 ml.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Daiichi Sankyo Altkirch
Marketing authorisation date:
Manufacturing sites for batch release:
- Vericore Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10404/001/002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
